Search
for
Sort by
Research 61–90 of 1000+
- Transudation of phVEGF165 into sclerotic skin to promote hair growth and regeneration in mice
- Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response.
- Interfacial Adipose Tissue in Systemic Sclerosis
- Experimental Production of Cutaneous Calcinosis and Sclerosis with Dihydrotachysterol (AT-10) 1
- Alopecia Universalis in a Multiple Sclerosis Patient After Switching From Rituximab to Ocrelizumab: A Case Report
- Role of isoflavones in multiple sclerosis
- Exploring the Dermoscopic Patterns in Tuberous Sclerosis
- BH25 Alopecia in a patient undergoing multiple treatments for multiple sclerosis: a rare presentation and case review
- 3162 Alopecia universalis after alemtuzumab in multiple sclerosis - a nine year follow up and review of literature
- Capillaroscopic patterns in patients with systemic sclerosis, psoriasis and alopecia and their correlations with serum concentrations of several angiogenic markers
- Lanostane-type triterpenes from the sclerotium of Inonotus obliquus (Chaga mushrooms) as proproliferative agents on human follicle dermal papilla cells
- Paradise Nut Paradox: Alopecia Due to Selenosis from a Nutritional Therapy
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- Teriflunomide: A Once-daily Oral Medication for the Treatment of Relapsing Forms of Multiple Sclerosis
- Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- Does Post-Void Residual Volume Predict Worsening Urological Symptoms in Patients with Multiple Sclerosis?
- A different approach to hair analysis: Application to multiple sclerosis
- The Shifting Landscape of Disease-Modifying Therapies for Relapsing Multiple Sclerosis
- Erosive pustular dermatosis of the scalp and multiple sclerosis: just a coincidence?
- Post-marketing safety profile of cladribine in multiple sclerosis: a disproportionality analysis based on the FDA adverse event reporting system
- The emerging role of cellular senescence in amyotrophic lateral sclerosis
- Is Dutasteride a Therapeutic Alternative for Amyotrophic Lateral Sclerosis?
- Skin Lesions in a Daclizumab-treated Patient with Multiple Sclerosis
- Delayed Onset of Alopecia Areata in a Patient on Ocrelizumab for Multiple Sclerosis: A Case Report
- Alemtuzumab-Induced Secondary Autoimmune Skin Disorders as Side Effects of Multiple Sclerosis Therapy: Problem That Can Be Influenced or Fate? A Narrative Overview of The Literature A Neuroprotective Role of Vitamin D?
- Teriflunomide efficacy, safety and tolerability in patients with relapsing forms of multiple sclerosis
- Tamoxifen-induced androgenetic alopecia in a dialysis patient with sclerosing encapsulating peritonitis (SEP)